Beta Bionics
BBNX
Insidertransaktionen und Aktienkurs 2024-2026
Alle Insidertrades bei Beta Bionics
| Datum |
Typ |
Insider |
Position |
Ø-Preis |
Volumen |
|
29.6.2026
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
17,0 $ |
166.762 $ |
|
26.6.2026
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
17,0 $ |
174.012 $ |
|
24.6.2026
|
Verkauf |
Jones, Christy |
Aufsichtsrat |
15,0 $ |
21.090 $ |
|
24.6.2026
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
15,0 $ |
18.880 $ |
|
4.6.2026
|
Verkauf |
Jones, Christy |
Aufsichtsrat |
14,0 $ |
39.354 $ |
|
4.6.2026
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
12,3 $ |
3.385 $ |
|
2.6.2026
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
12,6 $ |
67.183 $ |
|
2.6.2026
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
12,6 $ |
55.194 $ |
|
2.6.2026
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
12,6 $ |
84.165 $ |
|
2.6.2026
|
Verkauf |
Saint, Sean |
President & CEO |
12,6 $ |
212.707 $ |
|
2.6.2026
|
Verkauf |
Russell, Steven Jon |
Chief Medical Officer |
12,6 $ |
53.227 $ |
|
22.5.2026
|
Verkauf |
Lezack, Adam |
Aufsichtsrat |
11,2 $ |
11.188 $ |
|
21.5.2026
|
Verkauf |
Lezack, Adam |
Aufsichtsrat |
10,0 $ |
9.950 $ |
|
21.5.2026
|
Verkauf |
Jones, Christy |
Aufsichtsrat |
10,0 $ |
19.880 $ |
|
4.3.2026
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
11,6 $ |
4.084 $ |
|
2.3.2026
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
12,4 $ |
10.310 $ |
|
2.3.2026
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
12,4 $ |
13.153 $ |
|
2.3.2026
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
12,4 $ |
17.652 $ |
|
2.3.2026
|
Verkauf |
Saint, Sean |
President & CEO |
12,4 $ |
41.832 $ |
|
2.3.2026
|
Verkauf |
Russell, Steven Jon |
Chief Medical Officer |
12,4 $ |
12.683 $ |
|
6.1.2026
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
30,1 $ |
66.221 $ |
|
2.1.2026
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
29,9 $ |
230.950 $ |
|
2.1.2026
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
29,5 $ |
590.680 $ |
|
4.12.2025
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
30,7 $ |
63.192 $ |
|
2.12.2025
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
29,3 $ |
25.112 $ |
|
2.12.2025
|
Verkauf |
Russell, Steven Jon |
Chief Medical Officer |
29,3 $ |
30.069 $ |
|
2.12.2025
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
29,3 $ |
31.184 $ |
|
2.12.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
29,3 $ |
41.862 $ |
|
2.12.2025
|
Verkauf |
Saint, Sean |
President & CEO |
29,3 $ |
96.163 $ |
|
1.12.2025
|
Verkauf |
Palasis, Maria |
Aufsichtsrat |
29,6 $ |
41.552 $ |
|
1.12.2025
|
Verkauf |
Lezack, Adam |
Aufsichtsrat |
29,6 $ |
41.543 $ |
|
31.10.2025
|
Verkauf |
Palasis, Maria |
Aufsichtsrat |
27,2 $ |
37.834 $ |
|
31.10.2025
|
Verkauf |
Lezack, Adam |
Aufsichtsrat |
27,3 $ |
37.780 $ |
|
3.10.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
21,9 $ |
108.077 $ |
|
1.10.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
20,9 $ |
311.806 $ |
|
8.9.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
21,1 $ |
209.151 $ |
|
5.9.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
21,0 $ |
2.100 $ |
|
5.9.2025
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
20,6 $ |
234.657 $ |
|
4.9.2025
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
20,0 $ |
136.180 $ |
|
2.9.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
18,9 $ |
27.578 $ |
|
2.9.2025
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
18,9 $ |
15.996 $ |
|
2.9.2025
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
18,9 $ |
20.542 $ |
|
2.9.2025
|
Verkauf |
Russell, Steven Jon |
Chief Medical Officer |
18,9 $ |
19.146 $ |
|
2.9.2025
|
Verkauf |
Saint, Sean |
President & CEO |
18,9 $ |
63.361 $ |
|
22.8.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
17,0 $ |
75.083 $ |
|
19.8.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
17,0 $ |
95.172 $ |
|
19.8.2025
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
16,6 $ |
268.376 $ |
|
2.6.2025
|
Verkauf |
Saint, Sean |
President & CEO |
18,0 $ |
61.525 $ |
|
2.6.2025
|
Verkauf |
Feider, Stephen |
Chief Financial Officer |
18,0 $ |
26.783 $ |
|
2.6.2025
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
18,0 $ |
19.948 $ |
|
2.6.2025
|
Verkauf |
Russell, Steven Jon |
Chief Medical Officer |
18,0 $ |
18.588 $ |
|
2.6.2025
|
Verkauf |
Hopman, Mark |
Chief Commercial Officer |
18,0 $ |
15.530 $ |
|
31.1.2025
|
Kauf |
Wellington Hadley Harbor Aggregator IV, L.p. |
Zehn-Prozent-Eigentümer |
17,0 $ |
17.000.000 $ |
|
31.1.2025
|
Verkauf |
Mensinger, Mike |
Chief Product Officer |
17,0 $ |
221 $ |
|
31.1.2025
|
Kauf |
Mensinger, Mike |
Chief Product Officer |
17,0 $ |
566.950 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Verfolge die Insiderkäufe in Echtzeit per Push in unserem Telegram-Channel.
Jetzt beitreten